CVKD
#4912
Cadrenal Therapeutics, Inc. - Common Stock
1.5 4 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.91%
Monthly Change
-23.38%
6 month change
-82.34%
Year Change
-72.10%
Previous Close
1.5 7
Open
1.5 4
Low
1.5 4
High
1.5 4
Volume
1
Financials
- Market Capitalization 5.49 M
- Employee 5
- Founded 2022
- CEO N/A
- Website www.cadrenal.com
- Headquarter Delaware, United States
- FIGI BBG019STRT20
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.02
Price to sales ratio
—
Dividends per share
16.5
Dividend yield %
243.36
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4901 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.18 USD | -75.00% | -77.50% | -77.22% | -88.61% | 5.63 M USD | ||
| 4909 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.52 USD | -3.70% | -1.89% | -11.86% | -48.00% | 5.58 M USD | ||
| 4913 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.85 USD | 0.00% | -4.15% | +18.59% | -29.52% | 5.48 M USD | ||
| 4922 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.34 USD | -8.22% | -6.29% | +12.61% | -6.29% | 5.39 M USD |
Frequently asked questions about Cadrenal Therapeutics, Inc. Common Stock
What is the Cadrenal Therapeutics, Inc. Common Stock stock price today?
The current price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 1.54. Over the past 24 hours, the stock has changed by -1.91%. Follow the CVKD chart for real-time price dynamics.
What is the stock ticker of Cadrenal Therapeutics, Inc. Common Stock?
Cadrenal Therapeutics, Inc. Common Stock trades under the ticker CVKD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cadrenal Therapeutics, Inc. Common Stock stock going up?
CVKD has changed by -8.88% over the last week, -23.38% over the last month, and -72.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cadrenal Therapeutics, Inc. Common Stock?
Cadrenal Therapeutics, Inc. Common Stock currently has a market capitalization of 5.49 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cadrenal Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Cadrenal Therapeutics, Inc. Common Stock reported earnings of -1.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cadrenal Therapeutics, Inc. Common Stock net income for the last quarter?
Cadrenal Therapeutics, Inc. Common Stock reported net income of -3.32 M for the last quarter. The previous quarter showed -2.5 M, which means net income changed by -33.09%.
How many employees does Cadrenal Therapeutics, Inc. Common Stock have?
As of the latest available data, Cadrenal Therapeutics, Inc. Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Cadrenal Therapeutics, Inc. Common Stock stock?
You can buy Cadrenal Therapeutics, Inc. Common Stock (CVKD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cadrenal Therapeutics, Inc. Common Stock stock?
Investing in Cadrenal Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CVKD chart and related analysis on metatrader.com as part of your research.